BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21300473)

  • 1. Stereotactic radiotherapy for adrenal gland metastases: university of Florence experience.
    Casamassima F; Livi L; Masciullo S; Menichelli C; Masi L; Meattini I; Bonucci I; Agresti B; Simontacchi G; Doro R
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):919-23. PubMed ID: 21300473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients.
    Scorsetti M; Alongi F; Filippi AR; Pentimalli S; Navarria P; Clerici E; Castiglioni S; Tozzi A; Reggiori G; Mancosu P; Ricardi U
    Acta Oncol; 2012 May; 51(5):618-23. PubMed ID: 22263925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy for treatment of adrenal metastases.
    Chawla S; Chen Y; Katz AW; Muhs AG; Philip A; Okunieff P; Milano MT
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):71-5. PubMed ID: 19250766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy.
    Torok J; Wegner RE; Burton SA; Heron DE
    Future Oncol; 2011 Jan; 7(1):145-51. PubMed ID: 21174545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
    Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
    BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Adrenal Metastases with Conventional or Hypofractionated Image-guided Radiation Therapy - Patterns and Outcomes.
    Buergy D; Rabe L; Siebenlist K; Stieler F; Fleckenstein J; Giordano FA; Wenz F; Boda-Heggemann J
    Anticancer Res; 2018 Aug; 38(8):4789-4796. PubMed ID: 30061250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy in the treatment of adrenal metastases.
    Ahmed KA; Barney BM; Macdonald OK; Miller RC; Garces YI; Laack NN; Haddock MG; Foote RL; Olivier KR
    Am J Clin Oncol; 2013 Oct; 36(5):509-13. PubMed ID: 22781389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
    Chance WW; Nguyen QN; Mehran R; Welsh JW; Gomez DR; Balter P; Komaki R; Liao Z; Chang JY
    Pract Radiat Oncol; 2017; 7(3):e195-e203. PubMed ID: 27743801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery.
    Franzese C; Franceschini D; Cozzi L; D'Agostino G; Comito T; De Rose F; Navarria P; Mancosu P; Tomatis S; Fogliata A; Scorsetti M
    Cancer Res Treat; 2017 Jan; 49(1):20-28. PubMed ID: 27121718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy for curative treatment of adrenal metastases.
    Rudra S; Malik R; Ranck MC; Farrey K; Golden DW; Hasselle MD; Weichselbaum RR; Salama JK
    Technol Cancer Res Treat; 2013 Jun; 12(3):217-24. PubMed ID: 23369155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
    Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
    Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors.
    Barney BM; Olivier KR; Macdonald OK; Fong de Los Santos LE; Miller RC; Haddock MG
    Am J Clin Oncol; 2012 Dec; 35(6):537-42. PubMed ID: 21659830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?
    Vautravers-Dewas C; Dewas S; Bonodeau F; Adenis A; Lacornerie T; Penel N; Lartigau E; Mirabel X
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e39-47. PubMed ID: 21377292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
    Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation.
    Guckenberger M; Wulf J; Mueller G; Krieger T; Baier K; Gabor M; Richter A; Wilbert J; Flentje M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):47-54. PubMed ID: 18977095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated stereotactic body radiotherapy in spinal metastasis - with or without epidural extension.
    Anand AK; Venkadamanickam G; Punnakal AU; Walia BS; Kumar A; Bansal AK; Singh HM
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):345-52. PubMed ID: 25726363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
    Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.